Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep

Danielle N McLennan; Christopher John H Porter; Glenn A Edwards; Steven W Martin; Anne C Heatherington; Susan A Charman

doi:10.1124/jpet.104.078790

Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep

Danielle N McLennan, Christopher John H Porter, Glenn A Edwards, Steven W Martin, Anne C Heatherington, Susan A Charman

Drug Delivery Disposition & Dynamics

Research output: Contribution to journal › Article › Research › peer-review

47 Citations (Scopus)

Original language	English
Pages (from-to)	345 - 351
Number of pages	7
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	313
Issue number	1
DOIs	https://doi.org/10.1124/jpet.104.078790
Publication status	Published - 2005

Access to Document

10.1124/jpet.104.078790

Cite this

McLennan, Danielle N ; Porter, Christopher John H ; Edwards, Glenn A ; Martin, Steven W ; Heatherington, Anne C ; Charman, Susan A. / Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep. In: Journal of Pharmacology and Experimental Therapeutics. 2005 ; Vol. 313, No. 1. pp. 345 - 351.

@article{ebc53f8c5f8e44b8989665297af07f9f,

title = "Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep",

author = "McLennan, {Danielle N} and Porter, {Christopher John H} and Edwards, {Glenn A} and Martin, {Steven W} and Heatherington, {Anne C} and Charman, {Susan A}",

year = "2005",

doi = "10.1124/jpet.104.078790",

language = "English",

volume = "313",

pages = "345 -- 351",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "1521-0103",

publisher = "American Society for Pharmacology & Experimental Therapeutics (ASPET)",

number = "1",

}

Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep. / McLennan, Danielle N; Porter, Christopher John H; Edwards, Glenn A; Martin, Steven W; Heatherington, Anne C; Charman, Susan A.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 313, No. 1, 2005, p. 345 - 351.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep

AU - McLennan, Danielle N

AU - Porter, Christopher John H

AU - Edwards, Glenn A

AU - Martin, Steven W

AU - Heatherington, Anne C

AU - Charman, Susan A

PY - 2005

Y1 - 2005

U2 - 10.1124/jpet.104.078790

DO - 10.1124/jpet.104.078790

M3 - Article

VL - 313

SP - 345

EP - 351

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 1521-0103

IS - 1

ER -